Medibio Limited (ASX:MEB) is an Australian listed company developing a Digital Mental Health Platform. Medibio’s patented biomarker is based on the circadian heart rate architecture and has been developed over 15 years of research involving more than 5000 patients. The company is currently conducting trials to support FDA approvals.

Medical Advisory Board

Stephen Pearce

Chairman – Advisory Board

Mr Pearce is the Chief Financial Officer of Fortescue Metals Group Ltd having joined Fortescue in March 2010. In that time he has raised approximately US$12 billion to support the growth of Fortescue’s iron ore operations. Mr Pearce is also Non-Executive Chairman of the Lion’s Eye Institute, a leading Eye Research Institute based in Perth, Western Australia.

Mr Pearce will provide strategic, commercial and corporate guidance to the Board of BPO.

Mr Pearce has extensive experience in debt and equity markets in Australia, Asia and the United States. Mr Pearce will advise the Board through this important phase of development funding and commercialisation.

Dr Stephen Addis

Dr Stephen Addis is a founding shareholder of Invatec and has over 30 years of experience in the medical field. Graduating from The Queens University of Belfast Northern Ireland in 1982 he obtained Specialist qualifications in psychiatry in 1987 and a postgraduate Master’s degree in science 1992. Dr Addis is Head of Psychiatry and Service Director at Fremantle Hospital, a large university teaching hospital in Fremantle, Western Australia.

In this role he has extensive experience running a large and complex mental health service, and was responsible for organizational governance, service development, budgetary accountability, clinical and professional standards and research.

Dr Addis has also held Senior clinical and managerial positions in North America, the United Kingdom and Australia, which has given him first-hand knowledge of health systems internationally and locally.

Dr Addis is currently the Principal Investigator for a phase 3 clinical trial and has fifteen years’ experience as Principal Investigator/Investigator on pharmaceutical research trials and over a decade of clinical research into the effects of mental illness upon the circadian heart rate. He has made regular academic presentations at conferences both nationally and internationally.

Professor Hans Stampfer

Professor Stampfer (MB BS W.Aust., FRANZCP), is a Professor of Psychiatry at the University of Western Australia and Consultant Psychiatrist at Joondalup teaching Hospital. As the discoverer of the relationship between circadian heart rate and mental illness, Prof Stampfer is an invaluable addition to Medical and Scientific Advisory Board.

He is highly regarded in the field of Psychiatric Research and has international publications on the relationship between circadian heart rate and mental illness.

In addition to the expertise he will make available to Medibio Professor Stampfer has agreed to take a key role in the Independent Validation Trails and any additional research, which will be undertaken by the company.